Pioneering burns surgeon John Burke, a creator of synthetic skin, has died

The artificial skin he helped develop has helped save many lives.

Benedict professor of surgery emeritus John F. Burke, M.D. '51, who in 1969 began a long research partnership with MIT professor of mechanical and biological engineering Joannis Yannas ’57 that led to the development of the first commercially reproducible, synthetic human skin—critical in the treatment of burn victims—died on November 2 in Lexington, Massachusetts.

In S.B. Sutton’s 1984 cover story, Harvard Magazine provided background on the work that Burke, Yannas, and other Harvard Medical School researchers were pursuing in their efforts to save the lives of burn victims.

 

You might also like

Five Questions with Javier Ortega-Hernández

A professor of evolutionary biology on what shaped life more than 500 million years ago

Five Questions with Peter R. Girguis

A Harvard professor of evolutionary biology on what lurks in the deep sea  

How AI Is Reshaping Supply Chains

Harvard Kennedy School lecturer on using AI to strengthen supply chains

Most popular

Two Years of Doxxing at Harvard

What happens when students are publicly named and shamed for their views?

A New Narrative of Civil Rights

Political philosopher Brandon Terry’s vision of racial progress

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Explore More From Current Issue

Student walking under bright stage lights shaped like smartphones displaying social media apps.

Two Years of Doxxing at Harvard

What happens when students are publicly named and shamed for their views?

Karla Cornejo Villavicencio smiling beside the pink cover of her novel "Catalina" featuring a jeweled star and eye.

Being Undocumented in America

Karla Cornejo Villavicencio’s writing aims to challenge assumptions. 

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options.